Skip to content

aTyr Pharma ATYR PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$7.66B+6.2%
Merck & Co. logo
Merck & Co.MRK
$25.43B+2.6%
United Therapeutics logo
United TherapeuticsUTHR
$1.84B+41.3%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$824K-40.2%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$1.09M-51.1%
Vor Biopharma logo
Vor BiopharmaVOR
$565K-90.6%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$54.88M-88.2%
Enterprise value$57.17M
P/S288.8×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is aTyr Pharma's PP&E (net)?
aTyr Pharma (ATYR) reported PP&E (net) of $4.24M in Q1 2026.
How has aTyr Pharma's PP&E (net) changed year-over-year?
aTyr Pharma's PP&E (net) decreased by 9.5% year-over-year, from $4.68M to $4.24M.
What is the long-term trend for aTyr Pharma's PP&E (net)?
Over 5 years (2020 to 2025), aTyr Pharma's PP&E (net) has grown at a 36.5% compound annual growth rate (CAGR), from $899K to $4.26M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.